Zydus settles patent case over Aptalis’ drug Canasa
Canasa is indicated to treat mildly to moderately active ulcerative colitis
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Natco gets US FDA nod to market renal disease drug
The product, as the first generic, will be launched shortly in the US market
Over 1,000 Jan Aushadhi Kendras to open in UP
The shops will be opened under the Pradhan Mantri Bhartiya Janaushadhi Pariyojana scheme
Repeated regulatory reprimands will erode investor confidence in DRL: Analysts
German regulator's observations on GMP violations include systemic data integrity issues
Divis Labs bags green nod
To modernise its bulk drug unit in Visakhapatnam which will entail a cost of Rs 100 crore
PharmaLytica 2017 kickstarts in Hyderabad
Over 100 new exhibitors participated in the event
Sun Pharma posts Q1FY18 results
India sales is at Rs 1,761 crores, down by five per cent over Q1 last year
Indian Pharmacovigilance Day 2017 conference held in Hyderabad
The agenda was well-crafted to suit the contemporary professional interests of the pharmacovigilance stakeholders in India
Merck and Baylor College of Medicine sign agreement for R&D in neglected diseases
The collaboration includes training and exchange of technical know-how in process development and formulation, filling knowledge…
CPhI India Report identifies two-tier manufacturing market and predicts increased acquisitions
CDSCO certification has improved international repute of India, but domestic companies call for urgent Government support to…